BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37660867)

  • 1. Steric hindrance and charge influence on the cytotoxic activity and protein binding properties of diruthenium complexes.
    Terán A; Ferraro G; Imbimbo P; Sánchez-Peláez AE; Monti DM; Herrero S; Merlino A
    Int J Biol Macromol; 2023 Dec; 253(Pt 1):126666. PubMed ID: 37660867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Analysis of the Inhibitory Mechanism of Aβ
    La Manna S; Panzetta V; Di Natale C; Cipollone I; Monti M; Netti PA; Terán A; Sánchez-Peláez AE; Herrero S; Merlino A; Marasco D
    Inorg Chem; 2024 May; 63(21):10001-10010. PubMed ID: 38742626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Equatorial Ligand Substitution on the Reactivity with Proteins of Paddlewheel Diruthenium Complexes: Structural Studies.
    Terán A; Ferraro G; Sánchez-Peláez AE; Herrero S; Merlino A
    Inorg Chem; 2023 Jan; 62(2):670-674. PubMed ID: 36597851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound-assisted synthesis of water-soluble monosubstituted diruthenium compounds.
    Terán A; Cortijo M; Gutiérrez Á; Sánchez-Peláez AE; Herrero S; Jiménez-Aparicio R
    Ultrason Sonochem; 2021 Dec; 80():105828. PubMed ID: 34798526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Equatorially connected diruthenium(II,III) units toward paramagnetic supramolecular structures with singular magnetic properties.
    Barral MC; Gallo T; Herrero S; Jiménez-Aparicio R; Torres MR; Urbanos FA
    Inorg Chem; 2006 May; 45(9):3639-47. PubMed ID: 16634596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Diruthenium Metallodrug as a Potent Inhibitor of Amyloid-β Aggregation: Synergism of Mechanisms of Action.
    La Manna S; Di Natale C; Panzetta V; Leone M; Mercurio FA; Cipollone I; Monti M; Netti PA; Ferraro G; Terán A; Sánchez-Peláez AE; Herrero S; Merlino A; Marasco D
    Inorg Chem; 2024 Jan; 63(1):564-575. PubMed ID: 38117944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming Resistance of Caco-2 Cells to 5-Fluorouracil through Diruthenium Complex Encapsulation in PMMA Nanoparticles.
    Coloma I; Parrón-Ballesteros J; Cortijo M; Cuerva C; Turnay J; Herrero S
    Inorg Chem; 2024 Jun; ():. PubMed ID: 38833385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The first open-paddlewheel structures in diruthenium chemistry: examples of intermediate magnetic behaviour between low and high spin in Ru2(5+) species.
    Barral MC; Gallo T; Herrero S; Jiménez-Aparicio R; Torres MR; Urbanos FA
    Chemistry; 2007; 13(36):10088-95. PubMed ID: 17907129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coordination capacity of cytosine, adenine and derivatives towards open-paddlewheel diruthenium compounds.
    Valentín-Pérez Á; Perles J; Herrero S; Jiménez-Aparicio R
    J Inorg Biochem; 2018 Oct; 187():109-115. PubMed ID: 30077945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of Reactions of Dirhodium and Diruthenium Paddlewheel Tetraacetate Complexes with Nucleophilic Protein Sites: Computational Insights.
    Tolbatov I; Marrone A
    Inorg Chem; 2022 Oct; 61(41):16421-16429. PubMed ID: 36194651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel μ-oxo-diruthenium(III,III)-ibuprofen-(4-aminopyridine) chloride derived from the diruthenium(II,III)-ibuprofen paddlewheel metallodrug shows anticancer properties.
    Alves SR; Santos RLSR; Fornaciari B; Colquhoun A; de Oliveira Silva D
    J Inorg Biochem; 2021 Dec; 225():111596. PubMed ID: 34601164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pH- and Time-Dependent Release of Phytohormones from Diruthenium Complexes.
    Coloma I; Cortijo M; Fernández-Sánchez I; Perles J; Priego JL; Gutiérrez C; Jiménez-Aparicio R; Desvoyes B; Herrero S
    Inorg Chem; 2020 Jun; 59(11):7779-7788. PubMed ID: 32412249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A paramagnetic precursor for polymeric supramolecular assemblies based on multiply bonded dimetal units: mu-acetato-acetonitriletris(mu-N,N'-diphenylformamidinato)diruthenium tetrafluoroborate dichloromethane hemisolvate.
    Angaridis P; Cotton FA; Murillo CA; Wang XP
    Acta Crystallogr C; 2005 Feb; 61(Pt 2):m71-3. PubMed ID: 15695894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into progressive ligand replacement from [Ru
    Inchausti A; Terán A; Manchado-Parra A; de Marcos-Galán A; Perles J; Cortijo M; González-Prieto R; Herrero S; Jiménez-Aparicio R
    Dalton Trans; 2022 Jun; 51(25):9708-9719. PubMed ID: 35699149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unusual structural features in the lysozyme derivative of the tetrakis(acetato)chloridodiruthenium(II,III) complex.
    Messori L; Marzo T; Sanches RN; Hanif-Ur-Rehman ; de Oliveira Silva D; Merlino A
    Angew Chem Int Ed Engl; 2014 Jun; 53(24):6172-5. PubMed ID: 24796316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aryl C-H amination by diruthenium nitrides in the solid state and in solution at room temperature: experimental and computational study of the reaction mechanism.
    Long AK; Timmer GH; Pap JS; Snyder JL; Yu RP; Berry JF
    J Am Chem Soc; 2011 Aug; 133(33):13138-50. PubMed ID: 21744780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The binding of diruthenium (II,III) and dirhodium (II,II) paddlewheel complexes at DNA/RNA nucleobases: Computational evidences of an appreciable selectivity toward the AU base pairs.
    Tolbatov I; Umari P; Marrone A
    J Mol Graph Model; 2024 May; 131():108806. PubMed ID: 38824876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of axial ligands on the spectroscopic and electrochemical properties of diruthenium compounds.
    Manowong M; Han B; McAloon TR; Shao J; Guzei IA; Ngubane S; Van Caemelbecke E; Bear JL; Kadish KM
    Inorg Chem; 2014 Jul; 53(14):7416-28. PubMed ID: 25004282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mixed-valence diruthenium(II,III) complex endowed with high stability: from experimental evidence to theoretical interpretation.
    Barresi E; Tolbatov I; Pratesi A; Notarstefano V; Baglini E; Daniele S; Taliani S; Re N; Giorgini E; Martini C; Da Settimo F; Marzo T; La Mendola D
    Dalton Trans; 2020 Oct; 49(41):14520-14527. PubMed ID: 33048079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two mixed valence diruthenium(II,III) isomeric complexes show different anticancer properties.
    Barresi E; Tolbatov I; Marzo T; Zappelli E; Marrone A; Re N; Pratesi A; Martini C; Taliani S; Da Settimo F; La Mendola D
    Dalton Trans; 2021 Jul; 50(27):9643-9647. PubMed ID: 34160519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.